Literature DB >> 1984933

Limb reconstruction with vascularized fibular grafts after bone tumor resection.

K L Brown1.   

Abstract

Limb-salvage operations are being used with increasing frequency for patients with malignant bone tumors. For children, when a biologic reconstruction is desired, the choice is often between conventional and vascularized fibular grafts. An experimental study was performed in dogs to compare the two types of fibular grafts for bridging segmental defects in the radius and ulna. Twenty-six adult dogs were divided into two groups and studied at intervals of two, three, four, six, and 12 months after transplantation. The conventional grafts healed by creeping substitution i.e., they were first partially resorbed before new bone was laid down. In contrast, the vascularized fibulae maintained their normal structure and hypertrophied by subperiosteal new bone formation. The conventional fibulae eventually hypertrophied but much later than the vascularized grafts. The vascularized grafts were stronger at four and six months. Between six and 12 months, both grafts remodeled to resemble the size and shape of the forearm bones they were replacing. These experimental results have influenced the treatment of patients. Vascularized fibular grafts are ideal for diaphyseal defects greater than 10 cm long, especially in very young children, a poorly vascularized bed, or when bone healing is delayed by chemotherapeutic agents. To maximize hypertrophy, an external fixator is used to immobilize the graft rather than a plate, which acts as a stress shield.

Entities:  

Mesh:

Year:  1991        PMID: 1984933

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  8 in total

1.  Custom-made intercalary endoprosthetic reconstruction for a parosteal osteosarcoma of the femoral diaphysis: A case report.

Authors:  Shi-Chang Zhao; Chang-Qing Zhang; Chun-Lin Zhang
Journal:  Oncol Lett       Date:  2015-08-24       Impact factor: 2.967

2.  [Bilateral fibula graft. Biological reconstruction following resection of malignant bone tumors].

Authors:  P-U Tunn; T K Moesta; H Delbrück
Journal:  Chirurg       Date:  2006-10       Impact factor: 0.955

3.  What Is the Outcome of Allograft and Intramedullary Free Fibula (Capanna Technique) in Pediatric and Adolescent Patients With Bone Tumors?

Authors:  Matthew T Houdek; Eric R Wagner; Anthony A Stans; Alexander Y Shin; Allen T Bishop; Franklin H Sim; Steven L Moran
Journal:  Clin Orthop Relat Res       Date:  2016-03       Impact factor: 4.176

4.  Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection.

Authors:  William C Eward; Vasileios Kontogeorgakos; Lawrence Scott Levin; Brian E Brigman
Journal:  Clin Orthop Relat Res       Date:  2009-08-22       Impact factor: 4.176

5.  Treatment of a fibular autograft non-union with a resulting deformity by stabilization, progressive correction and callotasis using an Ilizarov fixator: a case study.

Authors:  Yasser Elbatrawy; Giby C Philips
Journal:  Strategies Trauma Limb Reconstr       Date:  2011-04-12

6.  The use of Papineau technique for the treatment of diabetic and non-diabetic lower extremity pseudoarthrosis and chronic osteomyelitis.

Authors:  Vasilios D Polyzois; Spyridon P Galanakos; Vassiliki A Tsiampa; Ioannis D Papakostas; Nikiforos K Kouris; Adrian M Avram; Apostolos E Papalois; Ioannis A Ignatiadis
Journal:  Diabet Foot Ankle       Date:  2011-03-04

7.  Giant-cell tumour of proximal radius in a 50-year-old female with wrist drop: a rare case report.

Authors:  Anshul Dahuja; Rashmeet Kaur; Shiraz Bhatty; Simmi Garg; Kapil Bansal; Mandeep Singh
Journal:  Strategies Trauma Limb Reconstr       Date:  2017-03-31

8.  Bilateral fibular graft: biological reconstruction after resection of primary malignant bone tumors of the lower limb.

Authors:  Maya Niethard; Carmen Tiedke; Dimosthenis Andreou; Frank Traub; Mario Kuhnert; Mathias Werner; Per-Ulf Tunn
Journal:  Sarcoma       Date:  2013-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.